{
    "summary": "The Wayback Machine -\nhttp://web.archive.org/web/20240117184650/https://www.fiercepharma.com/\n\n  * Fierce Pharma\n  * Fierce Biotech\n  * Fierce Healthcare\n  * Fierce Life Sciences Events\n  * Advertise\n  * About Us\n\n  * Pharma\n\n    * Vaccines\n    * Asia\n    * Cell & Gene Therapy\n    * Drug Delivery\n    * Executives\n  * Manufacturing\n\n    * Facilities\n    * Recalls\n    * Warning Letters\n  * Marketing\n  * Special Reports\n  * Fierce 50\n\n    * Special Report\n    * Awards Gala\n\n  * Resources\n\n    * Podcasts\n    * Fierce Events\n    * Industry Events\n    * Webinars\n    * Whitepapers\n    * Survey\n  *  __Events\n\n  * Subscribe\n\nSubscribe\n\n  * Pharma\n\n    * Vaccines\n    * Asia\n    * Cell & Gene Therapy\n    * Drug Delivery\n    * Executives\n  * Manufacturing\n\n    * Facilities\n    * Recalls\n    * Warning Letters\n  * Marketing\n  * Special Reports\n  * Fierce 50\n\n    * Special Report\n    * Awards Gala\n\n  * Resources\n\n    * Podcasts\n    * Fierce Events\n    * Industry Events\n    * Webinars\n    * Whitepapers\n    * Survey\n  *  __Events\n\n  * Subscribe\n\n  * Fierce Pharma\n  * Fierce Biotech\n  * Fierce Healthcare\n  * Fierce Life Sciences Events\n  * Advertise\n  * About Us\n\nPharma\n\n### CAR-T hype faces infrastructure reality check\n\nAs CAR-T therapies expand, a systemic problem now threatens to pose a serious\nchallenge to the burgeoning drug class.\n\nAngus Liu __Jan 15, 2024 3:00am\n\n### Seagen patent invalidated in long-running Daiichi patent feud\n\nJan 17, 2024 11:46am\n\n### Bora buys out generics manufacturer Upsher-Smith for $210M\n\nJan 17, 2024 10:55am\n\n### GSK offloads more stake in consumer health spin-off Haleon\n\nJan 17, 2024 10:41am\n\n### Pharma staffers most satisfied with pay across many fields\n\nJan 17, 2024 9:30am\n\n### Lonza telegraphs hefty layoff round at California plant\n\nJan 17, 2024 8:21am\n\nMore News\n\n### Novo Nordisk resumes Wegovy obesity promotion with new TV ad\n\nJan 17, 2024 6:10am\n\n### CSL asks autoimmune patients what they want from therapies\n\nJan 16, 2024 11:14am\n\n### Merck's Keytruda once again bags imperfect cervical cancer nod\n\nJan 16, 2024 11:00am\n\n### Persistent HIV stigma threatens work to end transmission: survey\n\nJan 16, 2024 3:57am\n\nSee more stories __\n\nin case you missed it\n\n###  trending now\n\nAppeals court allows unique argument in Gilead legal battle\n\nJan 12, 2024 04:26pm\n\nTop 20 pharma companies by 2022 revenue\n\nApr 18, 2023 07:00am\n\nJPM24: Pfizer oncology head still eyes ADC deals under new org\n\nJan 11, 2024 04:03pm\n\nBioMarin\u2019s commercial chief Jeffrey Ajer hits the exit\n\nJan 12, 2024 03:28pm\n\nPharma\n\nCAR-T hype faces infrastructure reality check\n\nAs CAR-T therapies expand, a systemic problem now threatens to pose a serious\nchallenge to the burgeoning drug class.\n\nAngus Liu __Jan 15, 2024 08:00am\n\n###  Watch now\n\nSponsored\n\nWhy are FSP models gaining traction within clinical research?\n\nEdel Shaw, Director of PPD FSP Solutions, sits down to discuss functional\nservice provider models and their place in the world of drug development.\n\nSponsored by PPD __Nov 13, 2023 01:00pm\n\nSponsored\n\nImplementing effective FSP partnerships with PPD FSP Solutions\n\nOct 30, 2023 12:00pm\n\nSponsored\n\nHarnessing data powers marketing programs to enable precise targeting\n\nOct 16, 2023 12:00pm\n\nSponsored\n\nPharma marketing: Getting personalized with Fingerpaint Group\n\nOct 16, 2023 12:00pm\n\nSponsored\n\nPersonalizing marketing efforts through omnichannel capabilities\n\nOct 16, 2023 12:00pm\n\nSee more articles __\n\n  * Connect\n\n    * The Team\n    * Advertise\n  * Join Us\n\n    * Newsletters\n    * Resources\n    * RSS Feeds\n  * Our Brands\n\n    * Fierce Biotech\n    * Fierce Healthcare\n    * Fierce Pharma\n  * Our Events\n\n    * Life Sciences Events\n\n\u00a92024 Questex LLC All rights reserved.\n\nTerms of use\n\nPrivacy Policy\n\nPrivacy Settings\n\n###  \n  \n_Series: Supply Chain Sustainability and Responsibility_  \n\n###  \nEpisode 3:  The Need for Building a Resilient Supply Chain Organization  \n\n* * *\n\nWith an uncertain future due to various global disruptors, there is a need to\nbuild resilience into Supply Chain organizations.  To help mitigate\ndisruptions, many companies are investing in new technology implementations,\nbusiness models, or apply advanced analytics.  But to be truly sustainable,\nresiliency should be embedded into the DNA of an organization.  Organizational\nresiliency can be accomplished by building a connected workforce ecosystem\ninclusive of talent, capabilities, skills, and the ability to adapt to new\nways of working.  \n  \n\n## **January 22, 2024 @ 11:00a ET**\n\nClose\n\n",
    "links": "[]",
    "priceAndPlans": "Error: Timeout 30000ms exceeded. =========================== logs\n=========================== navigating to\n\"http://web.archive.org/web/20240117184650/https://www.fiercepharma.com/\",\nwaiting until \"load\"\n============================================================\n\n"
}